Investments
174Portfolio Exits
27Funds
13About Hatteras Venture
Hatteras Venture is a venture capital firm that focuses on seed and early-stage opportunities in biopharmaceuticals, medical devices, diagnostics, and related opportunities in the human medicine sectors. The company was founded in 2000 and is based in Durham, North Carolina.
Want to inform investors similar to Hatteras Venture about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Hatteras Venture News
Sep 11, 2023
DURHAM – Hatteras Venture Partners has added another $8 million to its ongoing raising for its Hatteras Venture Partners VII fund. According to an SEC filing, the Durham company as reached $135 million in commitments. Its goal for the fund is $250 million. Some 88 investors have now participated.
Hatteras Venture Investments
174 Investments
Hatteras Venture has made 174 investments. Their latest investment was in Veralox Therapeutics as part of their Series A - II on June 6, 2023.
Hatteras Venture Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/20/2023 | Series A - II | Veralox Therapeutics | $24M | No | Genesys Capital, Hatteras Venture, JDRF T1D Fund, NYBC Ventures, Pappas Ventures, Sanofi Ventures, and Undisclosed Investors | 2 |
5/30/2023 | Series B | 410 Medical | $7.5M | No | 1 | |
5/2/2023 | Series A | Ten63 Therapeutics | $15.9M | Yes | Alexandria Venture Investments, Draper Associates, Hatteras Venture, IndieBio, Morpheus Ventures, SOSV, The Sigma Group, and Undisclosed Investors | 3 |
4/19/2023 | Series E | |||||
4/3/2023 | Series A |
Date | 6/20/2023 | 5/30/2023 | 5/2/2023 | 4/19/2023 | 4/3/2023 |
|---|---|---|---|---|---|
Round | Series A - II | Series B | Series A | Series E | Series A |
Company | Veralox Therapeutics | 410 Medical | Ten63 Therapeutics | ||
Amount | $24M | $7.5M | $15.9M | ||
New? | No | No | Yes | ||
Co-Investors | Genesys Capital, Hatteras Venture, JDRF T1D Fund, NYBC Ventures, Pappas Ventures, Sanofi Ventures, and Undisclosed Investors | Alexandria Venture Investments, Draper Associates, Hatteras Venture, IndieBio, Morpheus Ventures, SOSV, The Sigma Group, and Undisclosed Investors | |||
Sources | 2 | 1 | 3 |
Hatteras Venture Portfolio Exits
27 Portfolio Exits
Hatteras Venture has 27 portfolio exits. Their latest portfolio exit was Qpex Biopharma on June 25, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/25/2023 | Acquired | 5 | |||
10/18/2022 | Acquired | 5 | |||
8/22/2022 | Acquired | 16 | |||
Date | 6/25/2023 | 10/18/2022 | 8/22/2022 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 5 | 5 | 16 |
Hatteras Venture Fund History
13 Fund Histories
Hatteras Venture has 13 funds, including Hatteras Venture Partners VII.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/11/2023 | Hatteras Venture Partners VII | $135M | 3 | ||
2/2/2023 | Hatteras Opportunity Fund I | $15.2M | 2 | ||
10/15/2020 | Hatteras Venture Partners VI | $137.3M | 4 | ||
1/23/2020 | Hatteras Evergreen Private Equity Fund | ||||
2/28/2017 | Venture Capital Multiplier Fund |
Closing Date | 9/11/2023 | 2/2/2023 | 10/15/2020 | 1/23/2020 | 2/28/2017 |
|---|---|---|---|---|---|
Fund | Hatteras Venture Partners VII | Hatteras Opportunity Fund I | Hatteras Venture Partners VI | Hatteras Evergreen Private Equity Fund | Venture Capital Multiplier Fund |
Fund Type | |||||
Status | |||||
Amount | $135M | $15.2M | $137.3M | ||
Sources | 3 | 2 | 4 |
Hatteras Venture Team
7 Team Members
Hatteras Venture has 7 team members, including current Founder, General Partner, Clay B. Thorp.
Name | Work History | Title | Status |
|---|---|---|---|
Clay B. Thorp | Founder, General Partner | Current | |
Name | Clay B. Thorp | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder, General Partner | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
